Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 795, doi. 10.1002/jcph.1688
- Publication type:
- Article
Works matching IS 00912700 AND DT 2020 AND VI 60 AND IP 7
Results: 15
1
2
Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 815, doi. 10.1002/jcph.1644
- By:
- Publication type:
- Article
3
Intuitive Global Insight Into COVID‐19 Clinical Research Activities—The "COVID‐19 Map of Hope".
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
4
Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 808, doi. 10.1002/jcph.1646
- By:
- Publication type:
- Article
5
Can Colchicine as an Old Anti‐Inflammatory Agent Be Effective in COVID‐19?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
6
Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patients With Ulcerative Colitis or Crohn's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 903, doi. 10.1002/jcph.1590
- By:
- Publication type:
- Article
7
TMPRSS2: Potential Biomarker for COVID‐19 Outcomes.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 801, doi. 10.1002/jcph.1641
- By:
- Publication type:
- Article
8
Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 860, doi. 10.1002/jcph.1585
- By:
- Publication type:
- Article
9
The Role of Clinical Pharmacology in Chemotherapy of Multidrug‐Resistant Plasmodium falciparum.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 830, doi. 10.1002/jcph.1589
- By:
- Publication type:
- Article
10
Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 931, doi. 10.1002/jcph.1588
- By:
- Publication type:
- Article
11
Mannuronic Acid in Low‐Risk and Intermediate‐1‐Risk Myelodysplastic Syndromes.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 879, doi. 10.1002/jcph.1587
- By:
- Publication type:
- Article
12
A Randomized, Doubled‐Blind Clinical Trial on the Effect of Zataria multiflora on Clinical Symptoms, Oxidative Stress, and C‐Reactive Protein in COPD Patients.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 867, doi. 10.1002/jcph.1586
- By:
- Publication type:
- Article
13
Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 915, doi. 10.1002/jcph.1584
- By:
- Publication type:
- Article
14
Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 889, doi. 10.1002/jcph.1582
- By:
- Publication type:
- Article
15
Assessment of Similarity in Antipsychotic Exposure‐Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 848, doi. 10.1002/jcph.1580
- By:
- Publication type:
- Article